NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.31, sa.6, ss.1002-1013, 2016 (SCI-Expanded)
Background. Kidney recipients maintaining a prolonged allograft survival in the absence of immunosuppressive drugs and without evidence of rejection are supposed to be exceptional. The ERA-EDTA-DESCARTES working group together with Nantes University launched a European-wide survey to identify new patients, describe them and estimate their frequency for the first time.